Natural Products and Derivatives as Leads to Cell Cycle Pathway Targets in Cancer Chemotherapy
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
279-308
Author(s):
David J. Newman, Gordon M. Cragg, Susan Holbeck and Edward A. Sausville
Modulating Cell Cycle: Current Applications and Prospects for Future Drug Development
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
309-336
Author(s):
Hala Gali-Muhtasib and Nadine Bakkar
Identifying Molecular Targets Mediating the Anticancer Activity of Histone Deacetylase Inhibitors: A Work in Progress
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
337-353
Author(s):
B. G. Gabrielli, R. W. Johnstone and N. A. Saunders
The Use of Synthetic Oligonucleotides as Protein Inhibitors and Anticode Drugs in Cancer Therapy: Accomplishments and Limitations
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
355-368
Author(s):
Marcella Faria and Henning Ulrich
Subcellular Detection and Localization of the Drug Transporter P-Glycoprotein in Cultured Tumor Cells
Journal:
Current Protein & Peptide Science
Volume:
3
Page:
653-670
Author(s):
A. Molinari, A. Calcabrini, S. Meschini, A. Stringaro, P. Crateri, L. Toccacieli, M. Marra, M. Colone, M. Cianfriglia and G. Arancia
Microsomal Prostaglandin E Synthase: A Key Enzyme in PGE2 Biosynthesis and Inflammation
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
1
Page:
167-175
Author(s):
P- J. Jakobsson, D. Engblom, A. Ericsson-Dahlstrand and A. Blomqvist
Endostatin: Preclinical Development as an Anticancer Agent
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
2
Page:
233-243
Author(s):
T. Bachelot, R. Pawliuk and E. Jouanneau
Recent Advances in the Diagnosis and Therapy of Primary Adrenal Insufficiency
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
2
Page:
251-272
Author(s):
Stefano Laureti, Fausto Santeusanio and Alberto Falorni
Inhibitor at the Gates, Inhibitor in the Chamber: Allosteric and Competitive Inhibitors of the Proteasome as Prospective Drugs
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
2
Page:
279-301
Author(s):
M. Gaczynska and P.A. Osmulski
Selective Cyclooxygenase-2 Inhibitors and Non-small Cell Lung Cancer
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
1851-1858
Author(s):
C. Gridelli, P. Maione, G. Airoma and A. Rossi